Neurological Nuance: Sporadic Burkitt's Lymphoma Presenting with Guillain–Barre Syndrome

Abstract

Burkitt's lymphoma (BL) is a high-grade mature B cell neoplasm. Primary lymphoma of the central nervous system (CNS) is very rare. In contrast, BL can be localized in any part of the body and may spread to the CNS. Peripheral nervous system impairment caused by BL has been thoroughly described. However, Guillain–Barre syndrome (GBS) does not commonly appear as an initial manifestation of BL. We presented the case of a young child with sporadic BL with neuromeningeal involvement and spinal cord compression whose first clinical manifestation was the appearance of GBS. Lymphoma should be taken into account, especially in children presenting with the clinical features of acute polyradiculoneuropathy.

Keywords

Guillain–Barre's syndrome - Burkitt's lymphoma - lymphoma - neurology

Publication History

Received: 01 February 2020

Accepted: 07 April 2020

Article published online:
12 May 2020

• References

• 1 Sherief LM, Elsafy UR, Abdelkhalek ER, Kamal NM, Youssef DM, Elbehedy R. Disease patterns of pediatric non-Hodgkin lymphoma: a study from a developing area in Egypt. Mol Clin Oncol 2015; 3 (01) 139-144
• 2 NCCN. Non-Hodgkin's Lymphomas NCCN Clinical Practice Guidelines in Oncology, v1. 2010. Fort Washington, PA: NCCN; 2010
• 3 Dozzo M, Carobolante F, Donisi PM. et al. Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther 2016; 8: 11-29
• 4 Ostrom QT, Gittleman H, Fulop J. et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-oncol 2015; 17 (04) (Suppl. 04) iv1-iv62
• 5 Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve 2005; 31 (03) 301-313
• 6 Gutiérrez LC, Plascencia ÁNI, Quiñones AS, Venegas TA, Núñez OL. Síndrome de Guillain-Barré como manifestación paraneoplásica de linfoma No Hodgkin: Reporte de un caso. Rev Mex Neuroci 2008; 9 (03) 239-241
• 7 Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice?. J Neurol Neurosurg Psychiatry 2015; 86 (01) 115-119
• 8 Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014; 137 (Pt 1): 33-43
• 9 d'Amore F, de Nully Brown P, Weisenberger D. . Epidemiology of Extranodal Lymphomas. Extranodal Lymphomas, Pathology and Management. London: Informa Healthcare; 2008: 14-23
• 10 Bi C-F, Tang Y, Zhang WY. et al. Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases. Diagn Pathol 2012; 7 (01) 72
• 11 Dictor M, Ek S, Sundberg M. et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009; 94 (11) 1563-1568
• 12 Swerdlow SH, Campo E, Pileri SA. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20) 2375-2390
• 13 Toren A, Mandel M, Shahar E. et al. Primary central nervous system Burkitt's lymphoma presenting as Guillain-Barré syndrome. Med Pediatr Oncol 1994; 23 (04) 372-375
• 14 Guillain-Barre Syndrome Study Group. Guillain-Barré syndrome: an Italian multicentre case-control study. Neurol Sci 2000; 21 (04) 229-234
• 15 Ropper AH. Ischemic compression paresthesias in Guillain-Barré syndrome. Arch Neurol 1991; 48 (12) 1261-1262
• 16 van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol 2010; 30 (01) (Suppl. 01) S74-S78
• 17 Miles RR, Arnold S, Cairo MS. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia. Br J Haematol 2012; 156 (06) 730-743